中国寄生虫学与寄生虫病杂志 ›› 2024, Vol. 42 ›› Issue (2): 135-139.doi: 10.12140/j.issn.1000-7423.2024.02.001

• 专题报道 • 上一篇    下一篇

2023年全国疟疾疫情特征分析

张丽(), 夏志贵*()   

  1. 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心),传染病溯源预警与智能决策全国重点实验室,国家卫生健康委员会寄生虫病原与媒介生物学重点实验室,世界卫生组织热带病合作中心,科技部国家级热带病国际研究中心,上海 200025
  • 收稿日期:2024-03-29 修回日期:2024-04-07 出版日期:2024-04-30 发布日期:2024-04-22
  • 通讯作者: * 夏志贵(1976—),男,硕士,研究员,从事疟疾流行病学及控制与消除研究。E-mail:xiazg@nipd.chinacdc.cn
  • 作者简介:张丽(1981—),女,硕士,助理研究员,从事寄生虫病研究。E-mail:zhangli@nipd.chinacdc.cn

Epidemiological characteristics of malaria in China, 2023

ZHANG Li(), XIA Zhigui*()   

  1. National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention; Chinese Center for Tropical Diseases Research; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases; Key Laboratory on Parasite and Vector Biology, Ministry of Health; WHO Collaborating Centre for Tropical Diseases; National Center for International Research on Tropical Diseases, Ministry of Science and Technology, Shanghai 200025, China
  • Received:2024-03-29 Revised:2024-04-07 Online:2024-04-30 Published:2024-04-22
  • Contact: * E-mail: xiazg@nipd.chinacdc.cn

摘要:

收集、整理监测报告管理系统中2023年全国31个省(直辖市、自治区,未包括台湾、香港和澳门地区)和新疆生产建设兵团上报的疟疾流行病学个案调查表,对疟疾疫情特征进行统计分析。2023年全国报告疟疾病例2 488例,较2022年(845例)增加了194.4%。其中境外输入性病例2 487例,输血感染病例1例;恶性疟1 561例(占62.7%,1 561/2 488),间日疟615例(占24.7%,615/2 488),卵形疟234例(占9.4%,234/2 488),三日疟66例(占2.7%,66/2 488),混合感染12例(占0.5%,12/2 488);中国籍2 313例(占93.0%,2 313/2 488),外国籍175例(占7.0%,175/2 488);男女性别比为11.6∶1;30~39岁年龄组的病例最多(占29.1%,725/2 488)。31个省(直辖市、自治区)和新疆生产建设兵团均有疟疾病例报告,病例数位居前5位的省份依次为云南(398例)、河南(234例)、广西(195例)、山东(178例)和广东(174例),累计报告1 179例(占47.4%,1 179/2 488)。全国24个省份共报告危重症病例85例(占3.4%,85/2 488),死亡病例12例(占0.5%,12/2 488)。我国已连续7年无本土原发蚊传疟疾病例报告,但输入病例及其再传播风险持续存在。应继续加强监测与响应,及时发现和规范治疗疟疾病例,减少危重症或死亡病例,防止出现本地再传播。

关键词: 疟疾, 疫情特征, 中国

Abstract:

The individual malaria case investigation forms in 31 provinces/municipalities/autonomous regions (excluding Taiwan, Hong Kong and Macao) and Xinjiang Production and Construction Corps of China in 2023 were collected and sorted from “The Information System for Infectious Disease Surveillance”. The epidemiological characteristics were analyzed. In 2023, 2 488 malaria cases were reported, showing an increase of 194.4% compared to 2022 (845). Among them, there were 2 487 imported cases, 1 case of blood transfusion infection; 1 561 falciparum malaria cases (62.7%, 1 561/2 488), 615 vivax malaria (24.7%, 615/2 488), 234 ovale malaria (9.4%, 234/2 488), 66 malariae malaria (2.7%, 66/2 488) and 12 cases with mixed-infection (0.5%, 12/2 488). In the reported, 2 313 cases were of Chinese nationality (93.0%, 2 313/2 488) and 175 cases foreign nationality (7.0%, 175/2 488); the male-to-female ratio was 11.6∶1; the highest number of cases (29.1%, 725/2 488) was seen at the age group of 30-39 years showed. The malaria cases were reported from all the 31 provinces/municipalities/autonomous regions and Xinjiang Production and Construction Corps, with the top 5 provinces of Yunnan (398 cases), Henan (234 cases), Guangxi (195 cases), Shandong (178 cases) and Guangdong (174 cases) accumulately, a total of 1 179 cases (47.4%, 1 179/2 488) reported. Of the reported, 85 were severe cases (3.4%, 85/2 488) and 12 deaths (0.5%, 12/2 488). Although no local transmitted primary malaria cases have been reported in China for seven consecutive years, the risk of imported cases and re-transmission. It is imperative to continuousely strengthen the surveillance and response, find the cases timely and deliver standardized treatment, so as to reduce severe cases and death, preventing local re-transmission.

Key words: Malaria, Epidemiological characteristics, China

中图分类号: